Filing Details

Accession Number:
0001596783-21-000142
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-05 18:51:46
Reporting Period:
2021-10-01
Accepted Time:
2021-10-05 18:51:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1781820 Ricardo Pravda C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
Svp & Chief Hr Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-01 2,855 $54.94 15,690 No 4 M Direct
Common Stock Acquisiton 2021-10-01 963 $88.10 16,653 No 4 M Direct
Common Stock Disposition 2021-10-01 4,906 $132.68 11,747 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase Common Stock Disposition 2021-10-01 2,855 $0.00 2,855 $54.94
Common Stock Options to purchase Common Stock Disposition 2021-10-01 963 $0.00 963 $88.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,817 2029-07-22 No 4 M Direct
3,225 2030-07-30 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
  2. Includes restricted stock units.
  3. Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
  4. The options vest and become exercisable in four equal annual installments beginning on July 22, 2020.
  5. The options vest and become exercisable in four equal annual installments beginning on July 30, 2021.